Assignee
INTERCEPT PHARMACEUTICALS INC
US·51 granted patents·43 pending applications·260 citations·filing 2002–2025
Top patents by PatentIndex Score
94 records- 0197US9611289B2Farnesoid X receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2014·Granted Apr 4, 2017·13 cites·20 claims
- 0296US10532061B2Farnesoid X receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted Jan 14, 2020·5 cites·6 claims
- 0396US9763964B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Sep 19, 2017·23 cites·7 claims
- 0495US7786102B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2006·Granted Aug 31, 2010·20 cites·3 claims
- 0594US9732116B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·20 cites·10 claims
- 0694US8377916B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2011·Granted Feb 19, 2013·15 cites·4 claims
- 0794US7932244B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsINTERCEPT PHARMACEUTICALS INC·Filed 2007·Granted Apr 26, 2011·24 cites·8 claims
- 0893US10052337B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Aug 21, 2018·21 cites·19 claims
- 0992US7858608B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsINTERCEPT PHARMACEUTICALS INC·Filed 2009·Granted Dec 28, 2010·21 cites·5 claims
- 1092US7812011B2Steroid agonist for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2005·Granted Oct 12, 2010·18 cites·11 claims
- 1191US7994352B2Process for preparing 3a(β)-7a(β)-dihydroxy-6a(β)-alkyl-5β-cholanic acidINTERCEPT PHARMACEUTICALS INC·Filed 2006·Granted Aug 9, 2011·22 cites·39 claims
- 1290US9238673B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Jan 19, 2016·12 cites·23 claims
- 1388US2024398834A1Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1487US11345721B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2020·Granted May 31, 2022·2 cites·6 claims
- 1587US10800807B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Oct 13, 2020·3 cites·17 claims
- 1687US10758549B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2020·Granted Sep 1, 2020·2 cites·33 claims
- 1787US9732117B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Aug 15, 2017·3 cites·10 claims
- 1887US2026000682A1Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1986US2023233581A1Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2085US10894054B2FXR agonist compositions for combination therapyINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Jan 19, 2021·3 cites·8 claims
- 2184US9777038B2Process for preparing bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Oct 3, 2017·3 cites·6 claims
- 2284US9650409B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted May 16, 2017·4 cites·8 claims
- 2384US9243027B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Jan 26, 2016·5 cites·17 claims
- 2484US2025011360A1Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2583US11034717B2Farnesoid X receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Jun 15, 2021·3 cites·10 claims
- 2683US10646499B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted May 12, 2020·1 cites·20 claims
- 2783US2023340010A1Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2882US10815267B23-desoxy derivative and pharmaceutical compositions thereofINTERCEPT PHARMACEUTICALS INC·Filed 2017·Granted Oct 27, 2020·1 cites·4 claims
- 2982US9540414B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2014·Granted Jan 10, 2017·4 cites·2 claims
- 3081US11000532B2Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2019·Granted May 11, 2021·0 cites·16 claims
- 3181US10421772B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2017·Granted Sep 24, 2019·1 cites·8 claims
- 3281US10047117B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Aug 14, 2018·2 cites·13 claims
- 3381US9090652B2Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Jul 28, 2015·3 cites·9 claims
- 3481US8969330B2Steroids as agonists for FXRINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Mar 3, 2015·2 cites·7 claims
- 3580US11066437B2Methods and intermediates for the preparation of bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted Jul 20, 2021·2 cites·22 claims
- 3679US2025376488A1Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3778US2025367217A1Pharmaceutical compositions for combination therapyINTERCEPT PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3878US2025367216A1Pharmaceutical compositions for combination therapyINTERCEPT PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3977US12337003B2Pharmaceutical compositions for combination therapyINTERCEPT PHARMACEUTICALS INC·Filed 2022·Granted Jun 24, 2025·0 cites·18 claims
- 4077US11311557B2Pharmaceutical compositions for combination therapyINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Apr 26, 2022·1 cites·16 claims
- 4177US2021228599A1Farnesoid x receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4275US12291549B2Farnesoid X receptor modulatorsINTERCEPT PHARMACEUTICALS INC·Filed 2021·Granted May 6, 2025·0 cites·2 claims
- 4375US2022133745A1Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4474US10751349B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2019·Granted Aug 25, 2020·0 cites·22 claims
- 4574US10155787B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Dec 18, 2018·1 cites·15 claims
- 4673US2021395293A1Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4772US2021269473A1Tgr5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4870US11807659B2TGR5 modulators and methods of use thereofINTERCEPT PHARMACEUTICALS INC·Filed 2022·Granted Nov 7, 2023·0 cites·15 claims
- 4970US11319337B23-desoxy derivative and pharmaceutical compositions thereofINTERCEPT PHARMACEUTICALS INC·Filed 2020·Granted May 3, 2022·0 cites·9 claims
- 5070US10987362B2Treatment of fibrosis using FXR ligandsINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted Apr 27, 2021·0 cites·5 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when INTERCEPT PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →